Gastric cancer is common in China [1-42],and its early diagnosis and treatment in advanced stage are difficult [31-50].In recent years ,gene study in cancer is a hotspot ,and great progress has been achieved [41-80] ....Gastric cancer is common in China [1-42],and its early diagnosis and treatment in advanced stage are difficult [31-50].In recent years ,gene study in cancer is a hotspot ,and great progress has been achieved [41-80] .Cancer gene therapy has shifted from the imagination into the laboratory and clinical trials.展开更多
研究显示,肾移植术后恶性肿瘤(malignancy after renal transplantation,MART)的发生风险呈逐年增加,在我国约为2.2%[1]。与西方国家的好发类型不同,我国大多以泌尿系统肿瘤最为常见,所占比率约50%[2]。尽管乳腺癌所占比例较低,但移植...研究显示,肾移植术后恶性肿瘤(malignancy after renal transplantation,MART)的发生风险呈逐年增加,在我国约为2.2%[1]。与西方国家的好发类型不同,我国大多以泌尿系统肿瘤最为常见,所占比率约50%[2]。尽管乳腺癌所占比例较低,但移植受者相对于普通人群在相同癌症阶段具有确诊年龄小,侵袭性高和预后差的特点[3-5]。移植物保护和肿瘤治疗的平衡是临床医生遇到的难题,国内外对于肾移植后新发乳腺癌的报道侧重于发病因素和病理分析,关于综合治疗的策略鲜有报道且参差不齐,导致这类患者的预后存在较大差异。本文报道我院2021年3月确诊的1例肾移植术后17年新发乳腺癌患者,对其各阶段治疗进行了密切随访和全面分析,旨在提倡积极开展多学科讨论,为此类患者制定个体化的精准治疗方案。展开更多
文摘Gastric cancer is common in China [1-42],and its early diagnosis and treatment in advanced stage are difficult [31-50].In recent years ,gene study in cancer is a hotspot ,and great progress has been achieved [41-80] .Cancer gene therapy has shifted from the imagination into the laboratory and clinical trials.
文摘研究显示,肾移植术后恶性肿瘤(malignancy after renal transplantation,MART)的发生风险呈逐年增加,在我国约为2.2%[1]。与西方国家的好发类型不同,我国大多以泌尿系统肿瘤最为常见,所占比率约50%[2]。尽管乳腺癌所占比例较低,但移植受者相对于普通人群在相同癌症阶段具有确诊年龄小,侵袭性高和预后差的特点[3-5]。移植物保护和肿瘤治疗的平衡是临床医生遇到的难题,国内外对于肾移植后新发乳腺癌的报道侧重于发病因素和病理分析,关于综合治疗的策略鲜有报道且参差不齐,导致这类患者的预后存在较大差异。本文报道我院2021年3月确诊的1例肾移植术后17年新发乳腺癌患者,对其各阶段治疗进行了密切随访和全面分析,旨在提倡积极开展多学科讨论,为此类患者制定个体化的精准治疗方案。
